NEGR1 and glioblastoma: In glioblastomas, YAP confers invasiveness by upregulating miR296-3p as well as other canonical YAP targets (neuronal growth regulator 1 (NEGR1), matrix metalloproteinase 1 (MMP1), endothelin 1 (EDN1), CYR61, and CTGF).